Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNCE and other ETFs, options, and stocks.
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its products pipeline include JTX-2011 (ICOS); JTX-4014 (PD-1); Lead Macrophage Program; Macrophage Targeting; T Reg; B Cells; and Stromal Targeting.
52 Week High
52 Week Low
— per share
Expected Nov 4, Pre-Market